|
|
|
|
 |
|
|
|
After 2 regimen failures: identify their actual susceptibility zone
PhenoSense GT™ gives you the complete picture of resistance. It's the only assay that combines actual phenotype and genotype drug resistance data. Our updated report form is easy to read, user-friendly, and comprehensive. We've introduced upper and lower clinical cutoffs, along with a new, highly practical summary page. Even in complex cases, PhenoSense GT™ brings clarity to your treatment choices.
The updated upper and lower clinical cutoffs reveal valuable treatment options, especially for patients with multidrug resistance. A result above the upper cutoff indicates resistance. A result below the lower cutoff indicates sensitivity. A result between the cutoffs indicates partial susceptibility. PhenoSense GT™ also includes data on replication capacity (RC), a novel marker that may indicate the aggressive nature (fitness) of a patient's virus.
While sophisticated in its technology, PhenoSense GT™ remains user-friendly. One easy-to-read report features side-by-side actual phenotype and genotype results taken from a single patient sample. This comprehensive assay allows for advanced, practical insight into the resistance continuum, and overcomes limitations associated with either genotyping or phenotyping alone.
Give your patients a clear chance for success—make PhenoSense GT™ your drug resistance partner.
Click on the links below to learn more about PhenoSense GT™.
|
|
|
